Dorman Products: Positioned for Long-Term Growth and Innovation Amid Short-Term ChallengesWe model Q4 GM % -150bps y/y (to 40.2%) & suspect pressures could linger in '26, but the buyside is likely there based on convos; 2) Can LD sales grow HSD%+ y/y in Q4 despite a harder compare (+580bps q/q)? Our take: Yes, through a combination of pass-through pricing, innovation, & share gains; & 3) When could DORM return to M&A? Our take: It’s a matter of time as the B/S is healthy, HD/SV markets are prime for tuck-ins, etc.